Native macromolecular heparin proteoglycans exocytosed from stimulated rat serosal mast cells strongly inhibit platelet-collagen interactions

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 17, Issue 12, 1997, Pages 3578-3587

  Lassila, Riitta ^a   Lindstedt, Ken ^a   Kovanen, Petri T ^a  

^a WIHURI RESEARCH INSTITUTE   (Finland)

Author keywords

Collagen; Heparin; Mast cells; Platelet; Thrombosis

Indexed keywords

COLLAGEN; FIBRINOGEN; FIBRINOGEN RECEPTOR; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; MAGNESIUM; PROTEOGLYCAN; RISTOCETIN; SEROTONIN; THROMBIN; VERY LATE ACTIVATION ANTIGEN 2; VON WILLEBRAND FACTOR;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; EXOCYTOSIS; HUMAN; HUMAN CELL; MAST CELL; NONHUMAN; PRIORITY JOURNAL; RAT; SEROSA; SEROTONIN RELEASE; SHEAR RATE; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION;

EID: 0031444783     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.17.12.3578     Document Type: Article

References (12)

1. Kolodgie FD, Virmani R, Cornhill JF, Herderick EE, Smialek J. Increase in atherosclerosis and adventitial mast cells in cocaine abusers: an alternative mechanism of cocaine-associated coronary vasospasm and thrombosis. J Am Coll Cordial. 1991;17:1553-1560.
2. Galli SJ. New concepts about the mast cell. N Engl J Med. 1993; 328:257-265.
3. Kaartinen M, Penttilä A, Kovanen PT. Mast cells of two types differing in neutral protease composition in the human aortic intima: demonstration of tryptase- and tryptase/chymase-containing mast cells in normal intimas, fatty streaks and the shoulder region of atheromas. Arterioscler Thromb. 1994;14:966-972.
4. Kaartinen M, Penttilä A, Kovanen PT. Accumulation of activated mast cells in the shoulder region of human coronary atheroma, the predilection site of atheromatous rupture. Circulation. 1994;90:1669-1678.
5. Kovanen PT, Kaartinen M, Paavonen T. Infiltrates of activated mast cells at the site of coronary atheromatous erosion or rupture in myocardial infarction. Circulation. 1995;92:1084-1088.
6. 2+ associated with von Willebrand factor release in human endothelial cells exposed to histamines: study of microcarrier cell monolayers using the fluorescent probe Indo-1. J Clin Invest. 1987;79:600-608.
7. Wagner DD. The Weibel-Palade body: the storage granule for von Willebrand factor and P-selectin. Thromb Haemost. 1993;70:105-110.
8. Nader HB, Dietrich CP. Natural occurrence and possible biological role of heparin. In Lane DA, Lindahl U, eds. Heparin: Chemical and Biological Properties, Clinical Application. London: Edward Arnold; 1989:81-96.
9. Schoen P, Lindhout T, Franssen J, Hemker HC. Low molecular weight heparin-catalyzed inactivation of factor Xa and thrombin by antithrombin III: effect of platelet factor 4. Thromb Haemost. 1991; 66:435-441.
10. Rosenberg RD. Platelet heparitinase. Methods Enzymol. 1989;149:342-351.
11. Bochner BS, Lichtenstein LM. Anaphylaxis. N Engl J Med. 1991;324:1785-1790.
12. Fernandez F, N'guyen P, van Ryn J, Ofosu FA, Hirsh J, Buchanan MR. Hemorrhagic doses of heparin and other glycosaminoglycans induce a platelet defect. Thromb Res. 1986;43:491-495.